Other names |
NOS-1, NOSI, Type I NOS |
NOS-2, NOSII, Type II NOS |
NOS-3, NOSIII, Type III NOS |
Human chromosomal location |
12q24.2-12q24.3 |
17cen-q11.2 |
7q35–7q36 |
Human gene structure and size |
29 exons |
26 exons |
26 exons |
|
locus region >200 kbp |
37 kbp |
21–22 kbp |
Human monomer size (predominant form) |
161 kDa |
131 kDa |
133 kDa |
Splice variants |
Yes |
Yes |
No |
Typical site of expression |
Neurons |
Macrophages |
Endothelial cells |
Other major sites of expression |
Smooth muscle |
Smooth muscle |
Smooth muscle |
|
Skeletal muscle |
Liver |
Platelets |
Gene expression |
Constitutive and inducible |
Inducible |
Constitutive and inducible |
Ca2+ dependency |
Ca2+-dependent |
Practically Ca2+-independent |
Ca2+-dependent |
Covalent modifications |
Phosphorylation |
|
Myristoylation |
|
|
|
Palmitoylation |
|
|
|
Phosphorylation |
Protein–protein interactions |
hsp90, caveolin, NOSIP |
|
hsp90, caveolin |
Subcellular localization |
Neuromuscular junction |
Soluble |
Caveolae |
|
Soluble |
|
|
|
Sarcoplasmic reticulum |
|
|
Means of localization |
N-terminal PDZ domain (for membrane association) |
N/A |
N-terminal myristoylation |
NO production (range) |
Moderate (nM to μM) |
High (μM) |
Low (pm to nM) |